Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.

Paganin, M

Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia. [electronic resource] - Leukemia Dec 2008 - 2193-200 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1476-5551

10.1038/leu.2008.227 doi


Adolescent
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Asparaginase--therapeutic use
Child
Child, Preschool
Combined Modality Therapy
Cyclophosphamide--therapeutic use
Cytarabine--therapeutic use
Daunorubicin--therapeutic use
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation
Humans
Infant
Male
Mercaptopurine--therapeutic use
Methotrexate--therapeutic use
Multivariate Analysis
Neoplasm, Residual--drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Predictive Value of Tests
Prednisone--therapeutic use
Prognosis
Prospective Studies
Recurrence
Reverse Transcriptase Polymerase Chain Reaction
Risk Factors
Survival Analysis
Treatment Outcome
Vincristine--therapeutic use